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ering the brief time to the events from
the start of erlotinib (3, 3, 5, 21, and 58
days, respectively), it is highly probable.
Previous studies have shown that
EGFR was highly expressed in the epithe-
lium of the gastrointestinal tract, and se-
vere developmental disorders of the gas-
trointestinal epithelium were induced in
EGFR-knockout mice.3,4 Taking into ac-
count these preclinical data, our results
may not be so surprising.
In conclusion, erlotinib frequently
induces gastrointestinal ulcer when pa-
tients are administered NSAIDs without
antacids. Although antacids may weaken
the effectiveness of erlotinib by reducing
the blood concentration of erlotinib, on the
basis of our experiences, patients should
be given antacids to avoid gastrointestinal
ulcer when erlotinib and NSAIDs are ad-
ministered concomitantly.
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The Role of Surgery in
the Management of
Primary Thymic
Mucosa-associated
Lymphoid Tissue
(MALT) Lymphoma
To the Editor:
We read with great interest the
recent article in Journal of Thoracic
Oncology by Shimizu et al.,1 who pro-
posed a diagnosis flow chart (Figure 3)
for thymic mucosa-associated lymphoid
tissue (MALT) lymphoma. The diagno-
sis flow chart is creative and valuable
and presents a clear path of identifying
thymic MALT lymphoma. We extend
the topic by stressing the role of surgery
in the management of this rare disease.
As a malignant disease, thymic
MALT lymphoma must be diagnosed
finally by histologic examinations,
which are known as “golden standards.”
Given the extreme rarity of this disease,
some typical characteristics, as de-
scribed by Shimizu et al., may be im-
portant clues of thymic MALT lym-
phoma, but they are not yet “gold
standard” in diagnosis of this disease.
Thus, for exact histologic diagnosis, bi-
opsy is necessary. But in small biopsy,
such as percutaneous needle biopsy, it is
sometimes difficult to differentiate thymic
MALT lymphoma from thymoma be-
cause of similar histologic mixture of lym-
phoid cells and epithelial cells in small
biopsies.2 Then, surgery is usually un-
avoidable for enough tumor biopsy, as
reported in most cases of the literature.
On the other hand, according to
our experience and information from the
literature, thymic MALT lymphoma
seems to be a special lymphoma that
develops mostly within the thymus and
is often encapsulated by an intact mem-
brane.3 Local invasion or distal metasta-
sis is barely reported for this disease.
There should be no more difficulty to
perform a surgery on thymic MALT
lymphomas than on common thymomas.
Therefore, we suggest that when thymic
MALT lymphoma is highly suspected
by some typical characteristics, surgery
be reasonably recommended to manage
the anterior mediastinal mass. Surgery
should be performed not only as an
approach of obtaining enough tissues for
exact histologic diagnosis but also as a
choice of effective treatment by remov-
ing the disease completely.
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In Response:
We thank Song and coworkers
for their letter in response to our recent
article on primary thymic mucosa-as-
sociated lymphoid tissue (MALT)
lymphoma published in the Journal of
Thoracic Oncology.1 We recommended
the diagnostic flow chart for a cystic
thymic mass but did not address the
role of surgery in the management of
this rare disease.
Song and coworkers stressed the
role of surgery in the management of
thymic MALT lymphoma. They sug-
gested that surgery should be per-
formed not only as an approach of
obtaining enough tissues for exact his-
tologic diagnosis but also as a choice
of effective treatment by removing the
disease completely. We fully agree
with their opinion. As has been re-
ported in the literature, thymic MALT
lymphoma is often encapsulated, and
local invasion or distal metastasis has
barely been reported.1,2 If completely
resected before it spreads, excellent
outcome is expected. However, if the
disease is left untreated and spreads
beyond encapsulation, its management
can be challenging.
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